CaV3.2 Antibody (OASE00153)

Aviva Systems Biology

CaV3.2 Antibody (OASE00153)

23

ImmunoFluorescence, ImmunoPrecipitation, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, Other Application

Research Use Only

Monoclonal

N55/10 (Formerly sold as S55-10)

1 mg/ml

Unconjugated

CACNA1H

calcium voltage-gated channel subunit alpha1 H

CACNA1HB, Cav3.2, ECA6, EIG6, HALD4, voltage-dependent T-type calcium channel subunit alpha-1H, calcium channel, voltage-dependent, T type, alpha 1H subunit, calcium channel, voltage-dependent, T type, alpha 1Hb subunit, low-voltage-activated calcium channel alpha1 3.2 subunit, low-voltage-activated calcium channel alpha13.2 subunit, voltage dependent t-type calcium channel alpha-1H subunit, voltage-gated calcium channel alpha subunit Cav3.2, voltage-gated calcium channel alpha subunit CavT.2, voltage-gated calcium channel subunit alpha Cav3.2

Mouse

IgG1

CaV3.2 is a protein which in humans is encoded by the CACNA1H gene. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (1, 2). Studies also suggest that the up-regulations of CaV3.2 may participate in the progression of prostate cancer toward an androgen-independent stage (3).

-20°C

12352203